MicroPort Firebird 2 Successfully Registered in Ecuador

Shanghai, July 9, 2012--MicroPort announced the registration for MicroPort Firebird2 Rapamycin-Eluting CoCr Coronary Stent System has been approved by Ecuador's FDA. It is the third product has successfully launched in the country after Firebird and Mustang. Currently, Firebird2 has successfully entered into eight countries includes Philippines, Thailand, Indonesia, Argentina, Brazil, Venezuela, Peru, and Ecuador.